The ACE2-angiotensin-(1-7)-mas axis protects against pancreatic cell damage in cell culture

Pancreas

Volumn 44, Issue 2, 2015, Pages 266-272

  Wang, Jing ^a   Liu, Ruixia ^a   Qi, Haiyu ^a   Wang, Yan ^a   Cui, Lijian ^a   Wen, Yan ^a   Li, Huihui ^a   Yin, Chenghong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

ACE2; Angiotensin (1 7); Mas; Pancreatic cell damage; Protection effect

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MAS RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ANTIINFLAMMATORY AGENT; AUTACOID; CERULETIDE; DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; NITRIC OXIDE; NOS3 PROTEIN, RAT; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ACUTE PANCREATITIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL PROTECTION; CONTROLLED STUDY; NONHUMAN; PANCREAS CELL; PANCREAS INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; PANCREAS; PANCREATITIS; PATHOLOGY; PHOSPHORYLATION; TIME;

ANGIOTENSIN I; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CERULETIDE; CYTOPROTECTION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PANCREAS, EXOCRINE; PANCREATITIS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84925856083     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000247     Document Type: Article

References (53)

1. Kapoor K, Banks PA. Early prognostic evaluation of acute pancreatitis: an on-going challenge. JOP. 2013; 10: 109-11.
2. Neri V, Ambrosi A, Fersini A, et al. Severe acute pancreatitis: clinical forms of different gravity. Ann Ital Chir. 2013; 84: 47-53.
3. Gul R, Ramdas M, Mandavia CH, et al. RAS-mediated adaptive mechanisms in cardiovascular tissues: confounding factors of RAS blockade therapy and alternative approaches. Cardiorenal Med. 2012; 2: 268-280.
4. FerrarioCM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol. 2005; 289: H2281-H2290.
5. Osterreicher CH, Taura K, De Minicis S, et al. Angiotensin e converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology. 2009; 50: 929-938.
6. Verma A, Shan Z, Lei B, et al. ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy. Mol Ther. 2012; 20: 28-36.
7. Leung PS. The physiology of a local renin-angiotensin system in the pancreas. J Physiol. 2007; 1: 31-37.
8. Tsang SW, Ip SP, Leung PS. Prophylactic and therapeutic treatments with AT 1 and AT 2 receptor antagonists and their effects on changes in the severity of pancreatitis. Int J Biochem Cell Biol. 2004; 36: 330-339.
9. Oruc N, Ozutemiz O, Nart D, et al. Inhibition of renin angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target. Exp Toxicol Pathol. 2010; 62: 353-360.
10. Tsang SW, Cheng CH, Leung PS. The role of the pancreatic renin-angiotensin system in acinar digestive enzyme secretion and in acute pancreatitis. Regul Pept. 2004; 119: 213-219.
11. Zhang XP, Li ZJ, Zhang J. Inflammatory mediators and microcirculatory disturbance in acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2009; 8: 351-357.
12. Ibis M, Y?ksel O, Yilmaz G, et al. Serum angiotensin converting enzyme levels in pancreatic diseases. Hepatogastroenterology. 2008; 55: 1814-1817.
13. Ulmasov B, Xu Z, Talkad V, et al. Angiotensin II signaling through the AT1a and AT1b receptors does not have a role in the development of cerulein-induced chronic pancreatitis in the mouse. Am J Physiol Gastrointest Liver Physiol. 2010; 299: G70-G80.
14. Sampaio WO, Souza dos Santos RA, Faria-Silva R, et al. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007; 49: 185-192.
15. Wang Y, Wang J, Liu R, et al. Severe acute pancreatitis is associated with upregulation of the ACE2-angiotensin-(1-7)-Mas axis and promotes increased circulating angiotensin-(1-7). Pancreatology. 2012; 12: 451-457.
16. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005; 9: 59-71.
17. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002; 296: 1655-1657.
18. Fillmore GC, Wang Q, Carey MJ, et al. Expression of Akt (protein kinase B) and its isoforms in malignant lymphomas. Leuk Lymphoma. 2005; 46: 1765-1773.
19. Kennedy SG, Wagner AJ, Conzen SD, et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997; 11: 701-713.
20. Chan YC, Leung PS. Co-operative effects of angiotensin II and caerulein in NFκB activation in pancreatic acinar cells in vitro. Regul Pept. 2011; 166: 128-34.
21. Yu JH, Lim JW, Kim H. Altered gene expression in cerulein-stimulated pancreatic acinar cells: pathologic mechanism of acute pancreatitis. Korean J Physiol Pharmacol. 2009; 13: 409-416.
22. Gwathmey TM, Westwood BM, Pirro NT, et al. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. Am J Physiol Renal Physiol. 2010; 299: 983-990.
23. Pandol SJ, Saluja AK, Imrie CW, et al. Acute pancreatitis: bench to the bedside. Gastroenterology. 2007; 132: 1127-1151.
24. Sah RP, Saluja A. Molecular mechanisms of pancreatic injury. Curr Opin Gastroenterol. 2011; 27: 444-451.
25. Saluja AK, Lerch MM, Phillips PA, et al. Why does pancreatic overstimulation cause pancreatitis? Annu Rev Physiol. 2007; 69: 249-269.
26. Rakonczay Z Jr, Hegyi P, Takács T, et al. The role of NF-κB activation in the pathogenesis of acute pancreatitis. Gut. 2008; 57: 259-267.
27. Mayerle J, Dummer A, Sendler M, et al. Differential roles of inflammatory cells in pancreatitis. J Gastroenterol Hepatol. 2012; 27: 47-51.
28. Chang K, Lu W, Zhang K, et al. Rapid urinary trypsinogen-2 test in the early diagnosis of acute pancreatitis: a meta-analysis. Clin Biochem. 2012; 45: 1051-1056.
29. Kahl S, Mayer JM. Update on experimental acute pancreatitis. Minerva Gastroenterol Dietol. 2012; 58: 355-363.
30. Monos?ková J, Zeman M, Veselá A, et al. Down regulation of angiotensin II receptor AT1 expression in the pancreas of diabetic rat. Exp Clin Endocrinol Diabetes. 2009; 117: 438-439.
31. Leung PS, Chappell MC. A local pancreatic renin-angiotensin system: endocrine and exocrine roles. Int J Biochem Cell Biol. 2003; 35: 838-846.
32. Ram?rez-Sánchez M, Prieto I, Wangensteen R, et al. The renin-angiotensin system: newinsight into old therapies. Curr Med Chem. 2013; 20: 1313-1322.
33. Gonzalez NC, Allen J, Schmidt EJ, et al. Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol. 2007; 292: H2285-H2294.
34. Ulmasov B, Xu Z, Tetri LH, et al. Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G284-G294.
35. Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002; 277: 14838-14843.
36. Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of angiotensin-converting enzyme cloning and functional expression as a captopril-insensitive carboxpeptidase. J Biol Chem. 2000; 275: 33238-33243.
37. Ocaranza MP, Godoy I, Jalil JE, et al. 2006 Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension. 2006; 48: 572-578.
38. Bindom SM, Lazartigues E. The sweeter side of ACE2: physiological evidence for a role in diabetes. Mol Cell Endocrinol. 2009; 302: 193-202.
39. Bindom SM, Hans CP, Xia H, et al. Angiotensin-converting enzyme type 2 (ACE2) gene therapy improves glycemic normal in diabetic mice. Diabetes. 2010; 59: 2540-2548.
40. Santos RAS, Silva ACS, Maric C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A. 2003; 100: 8258-8263.
41. Ocaranza MP, Moya J, Barrientos V, et al. Angiotensin-(1-9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis. J Hypertens. 2014; 32: 771-783.
42. De Mello WC. Angiotensin (1-7) increases the potassium current and the resting potential of arterialmyocytes from vascular resistance vessels of normal adult rats: pathophysiological implications. J Am Soc Hypertens. 2014; 8: 14-20.
43. Klein N, Gembardt F, Sup? S, et al. Angiotensin-(1-7) protects from experimental acute lung injury. Crit Care Med. 2013; 41: e334-e343.
44. Ren YL, Garvin JL, Carretero OA. Vasodilator action of angiotensin (1-7) on isolated rabbit aferent arterioles. Hypertension. 2002; 39: 799-802.
45. da Silveira KD, Pompermayer Bosco KS, Diniz LR, et al. ACE2- angiotensin-(1-7)-Mas axis in renal ischaemia/reperfusion injury in rats. Clin Sci (Lond). 2010; 119: 385-394.
46. Wong TP, Ho KY, Ng EK, et al. Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport. Am J Physiol Endocrinol Metab. 2012; 303: E669-E681.
47. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy. 2002; 1: 343-351.
48. Malmstr?m ML, Hansen MB, Andersen AM, et al. Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis. Pancreas. 2012; 41: 271-277.
49. Dalbec KM, Max Schmidt C, Wade TE, et al. Adipokines and cytokines in human pancreatic juice: unraveling the local pancreatic inflammatory milieu. Dig Dis Sci. 2010; 55: 2108-2112.
50. Chan YC, Leung PS. Involvement of redox-sensitive extracellular-regulated kinases in angiotensin II-induced interleukin-6 expression in pancreatic acinar cells. J Pharmacol Exp Ther. 2009; 329: 450-458.
51. Aoun E, Chen J, Reighard D, et al. Diagnostic accuracy of interleukin-6 and interleukin-8 in predicting severe acute pancreatitis: a meta-analysis. Pancreatology. 2009; 9: 777-785.
52. Xu P, Wang J, Yang ZW, et al. Regulatory roles of the PI3K/Akt signaling pathway in rats with severe acute pancreatitis. PLoS One. 2013; 8: e81767.
53. Dias-PeixotoMF, Santos RAS, Gomes ERM, et al. Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes. Hypertension. 2008; 52: 542-548.